v3.26.1
Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (54,237) $ (105,452)
Adjustments to reconcile net loss to net cash flows    
Depreciation and amortization 75,409 68,800
Amortization of debt transaction costs 7,707 7,069
Foreign currency (gain) loss on debt (11,595) 23,845
Share based compensation expense 18,536 14,208
Interest income (23,389) (20,189)
Interest expense 69,169 79,635
Other 5,212 0
Changes in working capital:    
Increase in deferred revenue 815,130 703,005
Changes in other liabilities and assets (153,351) (166,125)
Increase in inventories (22,293) (273)
Changes in deferred tax assets and liabilities 2,335 1,257
Changes in other non-current assets and other non-current liabilities 16,362 (16,202)
Income taxes paid (2,829) (1,693)
Net cash flow from operating activities 742,166 587,885
Cash flows from investing activities    
Investments in property, plant and equipment and intangible assets (530,931) (146,294)
Loan to related party (36,882) 0
Proceeds from repayment of related party loan 31,251 0
Interest received 23,532 16,198
Net cash flow used in investing activities (513,030) (130,096)
Cash flows from financing activities    
Repayment of long-term debt (234,909) (54,054)
Proceeds from long-term debt 336,073 0
Transaction costs incurred for long-term debt (3,662) 0
Proceeds from issuance of ordinary shares from equity plans 5,115 5,457
Principal payments for lease liabilities (6,854) (7,346)
Interest payments for lease liabilities (4,570) (4,885)
Interest paid (83,183) (122,815)
Other (559) (867)
Net cash flow from (used in) financing activities 7,451 (184,510)
Change in cash and cash equivalents 236,587 273,279
Effect of exchange rate changes on cash and cash equivalents 837 2,604
Net increase in cash and cash equivalents 237,424 275,883
Cash and cash equivalents at January 1 3,803,944 2,489,672
Cash and cash equivalents at March 31 4,046,703 $ 2,765,555
Amendments to IFRS 9 and IFRS 7    
Cash flows from financing activities    
Cash and cash equivalents at January 1 $ 3,809,279